

ALLTOX funded research is published: “Multiple Epitope Presentation and Surface Density Control Enabled by Chemoselective Immobilization Lead to Enhanced Performance in IgE-binding Fingerprinting on Peptide Microarrays”. Tandem peptide technology provides an approximately twofold increased IgE binding capacity with respect to the linear and branched peptides, in the context of a Multiple Epitope Presentation (MPE) setting
Anal Chim Acta. 2017 Aug 29;983:189-197. doi: 10.1016/j.aca.2017.06.027
ALLTOX è un'attività del Laboratorio di Allergologia Cellulare e Molecolare diretto dal Dr. Samuele Burastero, presso l'Istituto Scientifico Ospedale San Raffaele, edificio DIBIT-1, via Olgettina, 58, 20132 Milano - LACM
Alltox
- In vitro determination of allergenicity of xenobiotics
- All-in-one molecular diagnosis of allergies
- Histamine intolerance
Admin tools
enter admin area